Application 022200
- Type
- NDA
- Sponsor
- ASTRAZENECA AB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BYDUREON | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG/VIAL | Yes | Yes |
| 002 | BYDUREON PEN | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022200-001 | BYDUREON | EXENATIDE SYNTHETIC | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | |
| N022200-002 | BYDUREON PEN | EXENATIDE SYNTHETIC | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022200-001 | 6515117 | 2025-10-04 | U-2588 | Drug substance, Drug product | 2017-11-17 |
| N022200-001 | 6515117*PED | 2026-04-04 | Pediatric extension | ||
| N022200-001 | 8329648 | 2026-08-18 | U-2588 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2589 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2590 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2593 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2594 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2595 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-2596 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-3188 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-3189 | 2013-01-10 | |
| N022200-001 | 8329648 | 2026-08-18 | U-3190 | 2013-01-10 | |
| N022200-001 | 8906851 | 2026-08-18 | U-2588 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-2589 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-2590 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-2593 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-3188 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-3189 | 2015-01-06 | |
| N022200-001 | 8906851 | 2026-08-18 | U-3190 | 2015-01-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2588 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2589 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2590 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2593 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2594 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2595 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-2596 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-3188 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-3189 | 2018-03-06 | |
| N022200-001 | 9884092 | 2026-08-18 | U-3190 | 2018-03-06 | |
| N022200-001 | 8329648*PED | 2027-02-18 | Pediatric extension | ||
| N022200-001 | 8906851*PED | 2027-02-18 | Pediatric extension | ||
| N022200-001 | 9884092*PED | 2027-02-18 | Pediatric extension | ||
| N022200-001 | 8501698 | 2027-06-20 | U-2588 | Drug product | 2017-11-17 |
| N022200-001 | 8501698*PED | 2027-12-20 | Pediatric extension | ||
| N022200-001 | 8361972 | 2028-03-21 | U-2588 | 2017-11-17 | |
| N022200-001 | 8361972*PED | 2028-09-21 | Pediatric extension | ||
| N022200-002 | 6515117 | 2025-10-04 | U-2588 | Drug substance, Drug product | 2017-11-15 |
| N022200-002 | 6515117*PED | 2026-04-04 | Pediatric extension | ||
| N022200-002 | 8329648 | 2026-08-18 | U-2588 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2589 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2590 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2593 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2594 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2595 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-2596 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-3188 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-3189 | 2014-03-28 | |
| N022200-002 | 8329648 | 2026-08-18 | U-3190 | 2014-03-28 | |
| N022200-002 | 8906851 | 2026-08-18 | U-2588 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-2589 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-2590 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-2593 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-3188 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-3189 | 2015-01-06 | |
| N022200-002 | 8906851 | 2026-08-18 | U-3190 | 2015-01-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2588 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2589 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2590 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2593 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2594 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2595 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-2596 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-3188 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-3189 | 2018-03-06 | |
| N022200-002 | 9884092 | 2026-08-18 | U-3190 | 2018-03-06 | |
| N022200-002 | 8329648*PED | 2027-02-18 | Pediatric extension | ||
| N022200-002 | 8906851*PED | 2027-02-18 | Pediatric extension | ||
| N022200-002 | 9884092*PED | 2027-02-18 | Pediatric extension | ||
| N022200-002 | 8501698 | 2027-06-20 | U-2588 | Drug product | 2017-11-15 |
| N022200-002 | 8501698*PED | 2027-12-20 | Pediatric extension | ||
| N022200-002 | 8361972 | 2028-03-21 | U-2588 | 2017-11-15 | |
| N022200-002 | 8361972*PED | 2028-09-21 | Pediatric extension |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2012-01-27 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2014-02-28 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022200-001 | BYDUREON | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2012-01-27 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022200-002 | BYDUREON PEN | 2MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2014-02-28 | 3bdfa0b2c4d7… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 6515117 | 2025-10-04 | U-2588 | Drug substance, Drug product | 2017-11-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 6515117*PED | 2026-04-04 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2590 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2589 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2595 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2593 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2596 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2588 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-2594 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-3188 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-3189 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648 | 2026-08-18 | U-3190 | 2013-01-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-2593 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-2589 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-2588 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-2590 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-3190 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-3189 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851 | 2026-08-18 | U-3188 | 2015-01-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2593 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2594 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2595 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2596 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2590 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2588 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-2589 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-3190 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-3189 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092 | 2026-08-18 | U-3188 | 2018-03-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8329648*PED | 2027-02-18 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8906851*PED | 2027-02-18 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 9884092*PED | 2027-02-18 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8501698 | 2027-06-20 | U-2588 | Drug product | 2017-11-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8501698*PED | 2027-12-20 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8361972 | 2028-03-21 | U-2588 | 2017-11-17 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-001 | 8361972*PED | 2028-09-21 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-002 | 6515117 | 2025-10-04 | U-2588 | Drug substance, Drug product | 2017-11-15 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N022200-002 | 6515117*PED | 2026-04-04 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N022200-002 | 8329648 | 2026-08-18 | U-2596 | 2014-03-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N022200-002 | 8329648 | 2026-08-18 | U-2595 | 2014-03-28 | d4dbc9d85df4… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022200-001 | NPP | 2024-07-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022200-001 | PED | 2025-01-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022200-002 | NPP | 2024-07-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022200-002 | PED | 2025-01-22 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022200-001 | NPP | 2024-07-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022200-001 | PED | 2025-01-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022200-002 | NPP | 2024-07-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022200-002 | PED | 2025-01-22 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022200-001 | NPP | 2024-07-22 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022200-001 | PED | 2025-01-22 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022200-002 | NPP | 2024-07-22 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022200-002 | PED | 2025-01-22 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022200-001 | NPP | 2024-07-22 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022200-001 | PED | 2025-01-22 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022200-002 | NPP | 2024-07-22 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022200-002 | PED | 2025-01-22 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022200-001 | NPP | 2024-07-22 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022200-001 | PED | 2025-01-22 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022200-002 | NPP | 2024-07-22 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022200-002 | PED | 2025-01-22 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022200-001 | NPP | 2024-07-22 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022200-001 | PED | 2025-01-22 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022200-002 | NPP | 2024-07-22 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022200-002 | PED | 2025-01-22 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022200-001 | NPP | 2024-07-22 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022200-001 | PED | 2025-01-22 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022200-002 | NPP | 2024-07-22 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022200-002 | PED | 2025-01-22 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022200-001 | NPP | 2024-07-22 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022200-001 | PED | 2025-01-22 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022200-002 | NPP | 2024-07-22 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022200-002 | PED | 2025-01-22 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022200-001 | NPP | 2024-07-22 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022200-001 | PED | 2025-01-22 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022200-002 | NPP | 2024-07-22 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022200-002 | PED | 2025-01-22 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022200-001 | NPP | 2024-07-22 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022200-001 | PED | 2025-01-22 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022200-002 | NPP | 2024-07-22 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022200-002 | PED | 2025-01-22 | 79d66fd596c7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceutica | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceutica | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82384 | SUPPL | 2025-06-02 |
| 82383 | SUPPL | 2025-06-02 |
| 82343 | SUPPL | 2025-05-29 |
| 80119 | SUPPL | 2024-11-05 |
| 80105 | SUPPL | 2024-11-04 |
| 73014 | SUPPL | 2022-12-23 |
| 73013 | SUPPL | 2022-12-23 |
| 72993 | SUPPL | 2022-12-22 |
| 71642 | SUPPL | 2022-07-27 |
| 71641 | SUPPL | 2022-07-27 |
| 71637 | SUPPL | 2022-07-27 |
| 71323 | SUPPL | 2022-06-15 |
| 71322 | SUPPL | 2022-06-15 |
| 71281 | SUPPL | 2022-06-13 |
| 68178 | SUPPL | 2021-07-26 |
| 68166 | SUPPL | 2021-07-22 |
| 62013 | SUPPL | 2020-03-03 |
| 62003 | SUPPL | 2020-03-02 |
| 57725 | SUPPL | 2019-02-21 |
| 57712 | SUPPL | 2019-02-20 |
| 56237 | SUPPL | 2018-11-01 |
| 53592 | SUPPL | 2018-04-03 |
| 53591 | SUPPL | 2018-04-03 |
| 50154 | SUPPL | 2017-10-24 |
| 50143 | SUPPL | 2017-10-23 |
| 38373 | SUPPL | 2015-10-07 |
| 38372 | SUPPL | 2015-10-07 |
| 17074 | SUPPL | 2015-10-07 |
| 38371 | SUPPL | 2015-10-06 |
| 29395 | SUPPL | 2015-09-28 |
| 7035 | SUPPL | 2015-09-28 |
| 7034 | SUPPL | 2015-09-28 |
| 7033 | SUPPL | 2015-09-28 |
| 38374 | SUPPL | 2015-09-23 |
| 7037 | SUPPL | 2015-09-22 |
| 7031 | SUPPL | 2015-05-05 |
| 17075 | SUPPL | 2015-03-27 |
| 7036 | SUPPL | 2015-03-11 |
| 17073 | SUPPL | 2015-03-09 |
| 29394 | SUPPL | 2015-03-06 |
| 42446 | SUPPL | 2014-08-05 |
| 38370 | SUPPL | 2014-05-28 |
| 17072 | SUPPL | 2014-05-28 |
| 29393 | SUPPL | 2014-05-27 |
| 7032 | SUPPL | 2014-05-27 |
| 7030 | SUPPL | 2014-03-05 |
| 17071 | SUPPL | 2014-03-04 |
| 44698 | ORIG | 2012-06-12 |
| 42445 | ORIG | 2012-06-12 |
| 17070 | ORIG | 2012-01-27 |
| 7029 | ORIG | 2012-01-27 |